employer cover photo
employer logo
employer logo

Transplant Genomics

Is this your company?

Toxic, unethical leadership and unsafe work culture, stay away. - Billing Representative Transplant Genomics Employee Review

1.0
13 Aug 2025
Recommend
CEO approval
Business outlook

Pros

A few truly talented, intelligent, and supportive colleagues. However, I’ve witnessed instances where lack of opportunities has led to the loss of truly exceptional individuals. Occasionally, there are opportunities to establish processes and improve workflows, mostly because there is a lack of those initiatives. Additionally, if you can overcome sabotage, lack of credit, and insufficient resources and support, you may have a chance to succeed. There's a lot of potential for this company to grow and be a big name in the market because what they do is exceptional as far as the science is concerned - but there are a lot of decisions made that are not financially smart or conducive to their success.

Cons

Retaliation Is the Norm: Speak up about anything — compliance gaps, discrimination, pay equity — and you will be excluded from meetings, stripped of resources, and publicly blamed for problems you didn’t cause. This is not accidental; it’s calculated and supported by HR both at TGI and Eurofins. ADA & FMLA Violations: Leadership knew about my documented health condition but refused accommodations. When I pursued legally protected medical leave, I was met with hostility and discouraged from even using words like “discrimination” or “accommodation" in gaslighting conversations. Pay and Title Manipulation: Merit increases were misrepresented. Mine had been approved but was intentionally withheld and lied about. Promotions are dodged by giving you more responsibility without the corresponding title or pay. For instance, I once received a promotion solely based on my title but was not assigned any actual duties, reserves, or support for that role. In another role, the job description was intentionally vague to assign the same tasks without being specific about the responsibilities for that role. Hostile Work Environment: Advancement is based on favoritism, not skill. Expect public undermining, information hoarding, and being left out of conversations that directly impact your work. Compliance Red Flags: Critical compliance concerns — including ones touching Medicare/Medicaid processes — were ignored or downplayed. Vendors were sometimes informed of internal changes before the team, creating operational and regulatory risk. Speaking up only makes you a target. High turnover and burnout are prevalent due to constant restructuring without a clear strategy. Employees leave quickly, and leadership views this as a positive outcome because it maintains silence.

Explore other reviews about Transplant Genomics

5.0
16 Jan 2025
Recommend
CEO approval
Business outlook

Pros

Well resourced, great and intelligent coworkers, powerful vision and mission

Cons

Some minor politics, but otherwise great

3.0
2 Feb 2026
Recommend
CEO approval
Business outlook

Pros

Great Team, Great Product, Solid Science & product. DEI program is fantastic.

Cons

Eurofins' management of Transplant Genomics and the Diagnostic arm of their testing is very poor. Decisions are made with the bottom line in mind and not of the product or longevity. 2 Major RIFs in 3 years. Paying 20% under going rate across the board.

1
See reviews by: Helpful|Rating|Date|All